Showing 1,981 - 2,000 results of 5,116 for search '(( significant clinical decrease ) OR ( significant ((larger decrease) OR (largest decrease)) ))', query time: 0.64s Refine Results
  1. 1981
  2. 1982
  3. 1983
  4. 1984

    Weight and plasma biochemistry. by Søren Egstrand (10906087)

    Published 2025
    “…<div><p>Secondary hyperparathyroidism (sHPT) is a significant clinical complication of CKD leading to bone abnormalities and cardiovascular disease. …”
  5. 1985
  6. 1986
  7. 1987
  8. 1988

    Data Sheet 1_Urinary microbiota changes among NMIBC patients during BCG therapy: comparing BCG responders and non-responders.docx by Toni Boban (20852165)

    Published 2025
    “…Patient inclusion criteria were male gender, no previous history of urothelial cancer, no other malignancies, no active infection, and no antibiotic usage for at least 20 days before the first BCG dose. We observed a significant decrease in biodiversity, measured by the Shannon Index, during the first week of therapy in 10 out of 12 patients (p=0.021). …”
  9. 1989

    Table 1_Impact of co-infections and immune responses on clinical severity of human adenovirus 3 and 7 infections in hospitalized children with lower respiratory tract infections: a... by Xiaolin Ma (701778)

    Published 2025
    “…</p>Conclusions<p>Hospitalized children with HAdV-7-associated LRTIs exhibit greater severity, multiple infections, and significant potential for greater cellular immune dysregulation compared to those with HAdV-3 infection, indicating a more severe clinical course and distinct pathogenic profiles.…”
  10. 1990
  11. 1991

    General data comparison. by Haifeng Chang (386047)

    Published 2024
    “…The proportion of patients under 60 years of age during the pandemic was higher than that after the pandemic. There was no significant difference in the average hospital stay between patients during and after the pandemic (P>0.05). …”
  12. 1992

    The epidemic period group. by Haifeng Chang (386047)

    Published 2024
    “…The proportion of patients under 60 years of age during the pandemic was higher than that after the pandemic. There was no significant difference in the average hospital stay between patients during and after the pandemic (P>0.05). …”
  13. 1993

    Original data. by Haifeng Chang (386047)

    Published 2024
    “…The proportion of patients under 60 years of age during the pandemic was higher than that after the pandemic. There was no significant difference in the average hospital stay between patients during and after the pandemic (P>0.05). …”
  14. 1994

    Post-epidemic group. by Haifeng Chang (386047)

    Published 2024
    “…The proportion of patients under 60 years of age during the pandemic was higher than that after the pandemic. There was no significant difference in the average hospital stay between patients during and after the pandemic (P>0.05). …”
  15. 1995

    Comparison of admissions by department. by Haifeng Chang (386047)

    Published 2024
    “…The proportion of patients under 60 years of age during the pandemic was higher than that after the pandemic. There was no significant difference in the average hospital stay between patients during and after the pandemic (P>0.05). …”
  16. 1996

    Table 1_Microbial diversity and composition in the gut microbiome of patients during systemic inflammatory response syndrome: can we use gut bacteria as potential biomarkers to cha... by Rafaela Ramalho Guerra (22106579)

    Published 2025
    “…</p>Results<p>During early AT, alpha diversity (Shannon index) was significantly lower in sepsis patients compared to non-sepsis patients (2.48 vs. 3.0, p = 0.01), whereas no significant difference was observed after prolonged treatment (2.65 vs. 2.89, p = 0.58). …”
  17. 1997
  18. 1998

    Description of the myofascial release techniques. by Sergio R. Thomaz (20308465)

    Published 2024
    “…There were significant decreases in the ΔMLwHFQ in the CRT group vs. …”
  19. 1999

    Study flow diagram. by Sergio R. Thomaz (20308465)

    Published 2024
    “…There were significant decreases in the ΔMLwHFQ in the CRT group vs. …”
  20. 2000

    Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”